SEC Filings

Filing date	Form	Description	View
03/01/24	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001558370-24-002267.pdf 0001558370-24-002267.rtf 0001558370-24-002267.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
09/27/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-009371.pdf 0001047469-13-009371.rtf 0001047469-13-009371.xls
10/29/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010050.pdf 0001047469-13-010050.rtf 0001047469-13-010050.xls
11/22/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010796.pdf 0001047469-13-010796.rtf 0001047469-13-010796.xls
04/08/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-003560.pdf 0001047469-14-003560.rtf 0001047469-14-003560.xls
04/30/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004381.pdf 0001047469-14-004381.rtf 0001047469-14-004381.xls
05/07/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004658.pdf 0001047469-14-004658.rtf 0001047469-14-004658.xls
08/01/13	10-12B	Registration filing of securities pursuant to section 12(b) of the Securities Exchange Act	View HTML 0001047469-13-007989.pdf 0001047469-13-007989.rtf 0001047469-13-007989.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools